Advertisement

Obesity Surgery

, Volume 19, Issue 6, pp 783–787 | Cite as

Use of Endoluminal Antireflux Therapies for Obese Patients with GERD

  • Brent WhiteEmail author
  • Louis O Jeansonne
  • Michael Cook
  • L. Felipe Chavarriaga
  • E. Adam Goldenberg
  • S. Scott Davis
  • C. Daniel Smith
  • Leena Khaitan
  • Edward Lin
Research Article

Abstract

Background

Obese patients with gastroesophageal reflux disease (GERD) refractory to medical therapy are a challenging patient population as obesity is a preoperative predictor of failure after antireflux surgery. We therefore sought to evaluate outcomes using one of two commercially available endoluminal therapies in this population.

Methods

Consecutive obese patients (body mass index (BMI) > 30) with GERD (DeMeester >14.5) undergoing either Plicator (NDO) or Stretta (Curon) were identified in our single-institution prospective database. Outcomes assessed were: (1) failure rate (absolutely no symptomatic improvement after procedure and/or need for subsequent antireflux surgery), (2) postoperative vs. preoperative symptom (heartburn, chest pain, regurgitation, dysphagia, cough, hoarseness, and asthma) scores, and (3) proton-pump inhibitor (PPI) medication use.

Results

Twenty-two patients each underwent an endoluminal therapy (ten Plicator patients and 12 Stretta patients) with mean follow-up of 1.5 years. There were no treatment-associated complications. Mean BMI was not different between Plicator and Stretta groups (39.6 vs. 38.6, respectively, p = 0.33). The failure rate for the entire cohort was 28% (10% Plicator vs. 42% Stretta, p = 0.11). The proportion of patients reporting moderate/severe symptoms postop was significantly less than preop: chest pain 9% vs. 13% (p = 0.04), cough 22% vs. 36% preop (p = 0.025), voice changes 9% vs. 36% preop (p = 0.012), and dysphagia 9% vs. 32% preop (p = 0.04). The proportion of patients on PPI medications postop was also less than preop (45% vs. 81%, p = 0.1)

Conclusion

Endoluminal treatment can provide a safe means of improving GERD symptoms for some obese patients, though many will continue to require medication therapy also. Further work aimed at understanding optimal candidates for endoluminal therapy in this patient population is warranted.

Keywords

Obesity GERD Endoluminal Plication Radiofrequency ablation 

References

  1. 1.
    Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002;288(14):1723–7.CrossRefGoogle Scholar
  2. 2.
    Mattar SG, Qureshi F, Taylor D, et al. Treatment of refractory gastroesophageal reflux disease with radiofrequency energy (Stretta) in patients after Roux-en-Y gastric bypass. Surg Endosc 2006;20(6):850–4.CrossRefGoogle Scholar
  3. 3.
    Lee HL, Eun CS, Lee OY, et al. GERD-related Erosive Esophagitis and Obesity. J Clin Gastroenterol 2008;0(0):0.Google Scholar
  4. 4.
    El-Serag HB, Ergun GA, Pandolfino J, et al. Obesity increases oesophageal acid exposure. Gut 2007;56(6):749–55.CrossRefGoogle Scholar
  5. 5.
    Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005;143(3):199–211.CrossRefGoogle Scholar
  6. 6.
    Nilsson M, Lagergren J. The relation between body mass and gastro-oesophageal reflux. Best Pract Res Clin Gastroenterol 2004;18(6):1117–23.CrossRefGoogle Scholar
  7. 7.
    Nilsson M, Johnsen R, Ye W, et al. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 2003;290(1):66–72.CrossRefGoogle Scholar
  8. 8.
    Nocon M, Labenz J, Jaspersen D, et al. Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study. J Gastroenterol Hepatol 2007;22(11):1728–31.CrossRefGoogle Scholar
  9. 9.
    Morgenthal CB, Lin E, Shane MD, et al. Who will fail laparoscopic Nissen fundoplication? Preoperative prediction of long-term outcomes. Surg Endosc 2007;21(11):1978–84.CrossRefGoogle Scholar
  10. 10.
    Perez AR, Moncure AC, Rattner DW. Obesity adversely affects the outcome of antireflux operations. Surg Endosc 2001;15(9):986–9.CrossRefGoogle Scholar
  11. 11.
    Kellogg TA, Andrade R, Maddaus M, et al. Anatomic findings and outcomes after antireflux procedures in morbidly obese patients undergoing laparoscopic conversion to Roux-en-Y gastric bypass. Surg Obes Relat Dis 2007;3(1):52–7; discussion 58–9.CrossRefGoogle Scholar
  12. 12.
    Kendrick ML, Houghton SG. Gastroesophageal reflux disease in obese patients: the role of obesity in management. Dis Esophagus 2006;19(2):57–63.CrossRefGoogle Scholar
  13. 13.
    Nelson LG, Gonzalez R, Haines K, et al. Amelioration of gastroesophageal reflux symptoms following Roux-en-Y gastric bypass for clinically significant obesity. Am Surg 2005;71(11):950–3; discussion 953–4.PubMedGoogle Scholar
  14. 14.
    Ortega J, Escudero MD, Mora F, et al. Outcome of esophageal function and 24-hour esophageal pH monitoring after vertical banded gastroplasty and Roux-en-Y gastric bypass. Obes Surg 2004;14(8):1086–94.CrossRefGoogle Scholar
  15. 15.
    Pleskow D, Rothstein R, Kozarek R, et al. Endoscopic full-thickness plication for the treatment of GERD: five-year long-term multicenter results. Surg Endosc 2008;22(2):326–32.CrossRefGoogle Scholar
  16. 16.
    Rothstein RI. Endoscopic therapy of gastroesophageal reflux disease: outcomes of the randomized-controlled trials done to date. J Clin Gastroenterol 2008;42(5):594–602.CrossRefGoogle Scholar
  17. 17.
    Wolfsen HC, Richards WO. The Stretta procedure for the treatment of GERD: a registry of 558 patients. J Laparoendosc Adv Surg Tech A 2002;12(6):395–402.CrossRefGoogle Scholar
  18. 18.
    Jeansonne L, White B, Nguyen V, et al. Endoluminal therapy for GERD: Outcomes comparison between full-thickness plication and radiofrequency treatment. Archives of Surgery (Accepted for Publication) 2008.Google Scholar
  19. 19.
    Triadafilopoulos G, Utley DS. Temperature-controlled radiofrequency energy delivery for gastroesophageal reflux disease: the Stretta procedure. J Laparoendosc Adv Surg Tech A 2001;11(6):333–9.CrossRefGoogle Scholar
  20. 20.
    Triadafilopoulos G. Clinical experience with the Stretta procedure. Gastrointest Endosc Clin N Am 2003;13(1):147–55.CrossRefGoogle Scholar
  21. 21.
    Triadafilopoulos G. Stretta: an effective, minimally invasive treatment for gastroesophageal reflux disease. Am J Med 2003;115(Suppl 3A):192S–200S.CrossRefGoogle Scholar
  22. 22.
    Triadafilopoulos G. Changes in GERD symptom scores correlate with improvement in esophageal acid exposure after the Stretta procedure. Surg Endosc 2004;18(7):1038–44.CrossRefGoogle Scholar
  23. 23.
    Triadafilopoulos G, DiBaise JK, Nostrant TT, et al. The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc 2002;55(2):149–56.CrossRefGoogle Scholar
  24. 24.
    Noar MD, Lotfi-Emran S. Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure. Gastrointest Endosc 2007;65(3):367–72.CrossRefGoogle Scholar
  25. 25.
    Pleskow D, Rothstein R, Kozarek R, et al. Endoscopic full-thickness plication for the treatment of GERD: long-term multicenter results. Surg Endosc 2007;21(3):439–44.CrossRefGoogle Scholar
  26. 26.
    Becker V, Bajbouj M, Waller K, et al. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors—a follow-up study of intraluminal-impedance guided therapy. Aliment Pharmacol Ther 2007;26(10):1355–60.CrossRefGoogle Scholar
  27. 27.
    Anvari M, Bamehriz F. Outcome of laparoscopic Nissen fundoplication in patients with body mass index >or = 35. Surg Endosc 2006;20(2):230–4.CrossRefGoogle Scholar
  28. 28.
    Frezza EE, Ikramuddin S, Gourash W, et al. Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass. Surg Endosc 2002;16(7):1027–31.CrossRefGoogle Scholar
  29. 29.
    Balsiger BM, Murr MM, Mai J, et al. Gastroesophageal reflux after intact vertical banded gastroplasty: correction by conversion to Roux-en-Y gastric bypass. J Gastrointest Surg 2000;4(3):276–81.CrossRefGoogle Scholar
  30. 30.
    Jones KB Jr. Roux-en-Y gastric bypass: an effective antireflux procedure in the less than morbidly obese. Obes Surg 1998;8(1):35–8.CrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2008

Authors and Affiliations

  • Brent White
    • 1
    Email author
  • Louis O Jeansonne
    • 1
  • Michael Cook
    • 1
  • L. Felipe Chavarriaga
    • 1
  • E. Adam Goldenberg
    • 1
  • S. Scott Davis
    • 1
  • C. Daniel Smith
    • 1
  • Leena Khaitan
    • 1
  • Edward Lin
    • 1
  1. 1.Emory Endosurgery UnitEmory School of MedicineAtlantaUSA

Personalised recommendations